Exercise Program for Multiple Myeloma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a specific exercise program can help older patients with multiple myeloma improve physical fitness and quality of life before undergoing CAR-T therapy. CAR-T modifies immune cells to target cancer cells but can cause side effects like muscle weakness and reduced physical function. Participants will follow a personalized exercise plan, including aerobic and resistance training, to determine its effectiveness in addressing these issues. The study seeks individuals aged 60 or older, diagnosed with multiple myeloma, and scheduled for CAR-T therapy. As an unphased trial, it offers a unique opportunity to contribute to research that may enhance patient care and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise program is safe for older patients with multiple myeloma?
A previous study found that regular aerobic and strength exercises are safe, with no harmful effects reported. This was especially true when patients followed the exercise program after treatments like autologous stem cell transplantation (ASCT). These results suggest that performing such exercises before starting CAR-T therapy can be safe for patients. The exercises aim to boost physical fitness and quality of life, potentially helping older patients with multiple myeloma feel better and stronger before their treatment.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how a personalized exercise program might support patients with multiple myeloma, a type of blood cancer. Unlike typical treatments such as chemotherapy, which directly target cancer cells, this approach focuses on improving patients' overall well-being through aerobic and resistance training. By using the Connected mHealth app and health coaching, it aims to enhance physical fitness, potentially improving quality of life and resilience during treatment. This trial seeks to discover if exercise can be a valuable complement to existing therapies like CAR-T, offering a holistic avenue for patient care.
What evidence suggests that prehabilitation with aerobic and resistance exercise is effective for improving outcomes in multiple myeloma patients undergoing CAR-T therapy?
Research has shown that aerobic and resistance exercises before treatment can enhance well-being and physical fitness in people with multiple myeloma. In this trial, participants in the supportive care arm will receive a personalized exercise plan and use the Connected mHealth app for aerobic and resistance training over 6 weeks. Studies have found that these exercise programs strengthen muscles and improve heart health, which is crucial for older patients undergoing treatments like CAR-T therapy. This type of exercise can also reduce fatigue and boost overall well-being. Evidence suggests that patients who exercise before medical treatments often recover better and function more effectively afterward. These findings highlight the potential benefits of exercise for those facing the challenges of multiple myeloma treatment.12367
Who Is on the Research Team?
Nadine H. Abdallah, MD
Principal Investigator
Mayo Clinic
Diane K. Ehlers, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for older patients with multiple myeloma that has either relapsed or is refractory, who are preparing to undergo CAR-T therapy. Participants should be able to engage in aerobic and resistance exercises as part of a prehabilitation program aimed at improving their physical fitness before treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation
Participants engage in personalized aerobic and resistance exercise prehabilitation activities for 6 weeks prior to CAR-T infusion
CAR-T Therapy
Participants undergo CAR-T cell infusion for treatment of multiple myeloma
Follow-up
Participants are monitored for safety and effectiveness after CAR-T infusion
What Are the Treatments Tested in This Trial?
Interventions
- CAR-T Therapy
- Prehabilitation with Aerobic and Resistance Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor